登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Distribution and nature of adverse events by study arm.
Distribution and nature of adverse events by study arm.
收藏
NIAID Data Ecosystem
2026-03-12 收录
HIV药物安全性监测
临床试验安全性评估
数据链接:
https://figshare.com/articles/dataset/Distribution_and_nature_of_adverse_events_by_study_arm_/13706627
数据链接
链接失效反馈
官方服务:
问题咨询
购买咨询
在线客服
NEW
资源简介:
Distribution and nature of adverse events by study arm.
应用场景:
创建时间:
2021-02-03
相关数据集
Risk of cancers assessed by the modified intention to treat model and by the per protocol model.
临床试验安全性评估
癌症风险统计模型
Abbreviations: mITT, modified intention to treat; NDA, New drug Approval; NMSC, non-melanoma skin cancers; OR, odds ratio; 95% CI, 95% confidence interval; *14 trials included for overall cancer analy
NIAID Data Ecosystem
6
0
Number of Grade 2–4* adverse events reported.
HIV药物安全性监测
临床试验不良事件
Number of Grade 2–4* adverse events reported.
Figshare
2015-12-02 更新
5
0
Side effects reported by female participants during the follow-up period by study arm.
药物不良反应监测
临床试验安全性评估
Side effects reported by female participants during the follow-up period by study arm.
Figshare
2022-02-17 更新
3
0
Safety outcomes in the patients who received an injection of the investigational product.
临床试验安全性评估
药物不良反应监测
Safety outcomes in the patients who received an injection of the investigational product.
Figshare
2019-12-10 更新
5
0
Number of subjects presenting possible or probable related adverse events.
药物不良事件
临床试验安全性评估
Number of subjects presenting possible or probable related adverse events.
NIAID Data Ecosystem
4
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广